Impact of Age-related Macular Degeneration on Daily Living Activitie
- Sponsor
- Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
- Study ID
- NCT06333873
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- patient-reported outcome — OTHERPerformance of real-life tests and tasks
Study Details
The complex and variable course of age-related diseases makes it all the more necessary to carry out personalised, reasoning-based examinations to improve the personalised assessment and management of AMD. However, functional assessment of AMD is most often based solely on visual acuity, and classifications of AMD are based solely on structural markers. There is therefore a need to improve the detection and functional assessment of this vision-threatening eye disease, by complementing and extending the standard assessments of clinical outcomes (COA)
Key Dates
- First listed
- Mar 27, 2024
- Start date
- Jun 30, 2024
- Status verified
- Mar 2024
- Primary completion
- Jun 30, 2029
- Completion
- Jun 30, 2029
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Other: Patients with early-stage AMD30Patients with early-stage AMD
- Other: Patients with intermediate-stage AMD30 with intermediate-stage AMD
- Other: 30 healthy volunteersWithout AMD risk
- Other: 30 healthy volunteers with central microdrusens (at risk of developing AMD)with central microdrusens (at risk of developing AMD)
Primary Outcome Measure
Validity of criteria [ Time Frame: 26 month ]
Central Contacts
- Nabil BROUK+33140021738
Find similar trials
Related Studies
- National Eye Institute Biorepository for Retinal DiseasesRecruiting · National Eye Institute (NEI) · Bethesda, Maryland
- High Resolution Retinal ImagingRecruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- Stem Cell Ophthalmology Treatment Study IIRecruiting · MD Stem Cells · Westport, Connecticut
- A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular DegenerationPHASE1 · Recruiting · Astellas Institute for Regenerative Medicine · Los Angeles, California